SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
02-Jan-24 4:39 PM View: | Diamedica Therapeutics Inc. (DMAC) | 02-Jan-24 | Grant | 21,428 | $2.80 | $59,998.40 | 56% 38.51K to 59.94K | |
03-Jan-22 4:21 PM View: | Diamedica Therapeutics Inc. (DMAC) | 03-Jan-22 | Grant | 16,773 | $3.58 | $60,047.30 | 77% 21.74K to 38.51K | |
12-Jan-21 4:12 PM View: | Trillium Therapeutics Inc. (TRIL) | 08-Jan-21 | Option Exercise | 8,505 | $7.24 | $61,616.20 | 100% 0 to 8.51K | |
12-Jan-21 4:12 PM View: | Trillium Therapeutics Inc. (TRIL) | 08-Jan-21 | Market Option Sale (Planned) | 8,505 | $15.79 | $134,271.00 | (100%) 8.51K to 0 | 49% |
04-Jan-21 4:21 PM View: | Diamedica Therapeutics Inc. (DMAC) | 01-Jan-21 | Grant | 7,745 | $8.23 | $63,741.30 | 55% 14.2K to 21.95K | |
02-Jun-20 4:49 PM View: | Diamedica Therapeutics Inc. (DMAC) | 01-Jun-20 | Grant | 8,102 | $4.59 | $37,188.20 | 133% 6.1K to 14.2K | 98% |
11-Dec-18 4:27 PM View: | Diamedica Therapeutics Inc. (DMAC) | 11-Dec-18 | Purchase | 2,250 | $4.00 | $9,000.00 | 58% 3.85K to 6.1K |